“…The common barriers to medication adherence for CVD include unaffordable costs, lack of belief in the necessity of medication, side effects of medication or medication concerns, complex regimens, forgetfulness, lack of family or social support, depression, lack of disease knowledge, and inconvenient access to medications or care ( Choudhry et al, 2011 ; Nair et al, 2011 ; Müller et al, 2015 ; Zullig et al, 2015 ; Banerjee et al, 2016 ; Crawshaw et al, 2016 ; Xavier et al, 2016 ; Wang et al, 2019 ). There are some uncommon barriers that are reported relatively less often such as asymptomatic diseases ( Devine et al, 2018 ), a poor provider–patient relationship, lack of understanding of the benefits of medication, prioritization issues or a busy lifestyle, disruptions to daily routines, and stigma or social embarrassment ( Quach et al, 2009 ; Gellad et al, 2011 ; Nair et al, 2011 ; Farsaei et al, 2014 ; Müller et al, 2015 ; Newman-Casey et al, 2015 ; Zullig et al, 2015 ; Campbell et al, 2016 ; Sweileh, 2018 ; Venditti et al, 2018 ; Federman et al, 2019 ; Sweileh et al, 2019 ). For CVD, there are several diseases or conditions that may be symptomless such as hypertension, hypercholesterolemia, and even coronary heart diseases in some cases.…”